MedRhythms Launches Clinical Trial of Stroke Asset on Walking Outcomes
MedRhythms Launches Clinical Trial of Stroke Asset on Walking Outcomes MedRhythms, a digital therapeutics company building direct stimulation solutions that use clinical-grade sensors, software and music to help restore function lost to neurologic disease or injury, announces the launch of a clinical trial that will study MR-010, MedRhythms’ acute stroke asset. The trial, conducted in partnership with and funded by UMass Memorial Healthcare, will examine the impact of MR-010 on acute stroke walking outcomes. Led by Dr. Brian Silver, Interim Chair in the UMass Department of Neurology, the ...